Skip to content

Clinical trials

Observational Hypercholesterolemia trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Phase: Observational Country / region: Italy Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20163
20171
20181
20202
20211
20221
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting4
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Federico II University4
Amgen2
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)1
Marcello Rattazzi1
Universita di Verona1
University of Bari1
University of Bari Aldo Moro1
University of Pisa1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia14
Atherosclerosis3
Cardiovascular Diseases2
Dyslipidemias2
Coronary Artery Disease1
Diabetes Insipidus1
Graves Ophthalmopathy1
Homozygous Familial Hypercholesterolemia1
Hypertension1
Lipid Metabolism Disorders1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.